The Long Pentraxin Ptx3 Is Synthesized in IgA Glomerulonephritis and Activates Mesangial Cells 1
暂无分享,去创建一个
[1] M. Byrne,et al. Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility. , 2002, Molecular endocrinology.
[2] Mauro M Teixeira,et al. Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury. , 2002, The American journal of pathology.
[3] C. Garlanda,et al. Production of the Long Pentraxin PTX3 in Advanced Atherosclerotic Plaques , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[4] A. Mantovani,et al. Long Pentraxin PTX3 Upregulates Tissue Factor Expression in Human Endothelial Cells: A Novel Link Between Vascular Inflammation and Clotting Activation , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[5] A. Mantovani,et al. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. , 2001, Arthritis and rheumatism.
[6] V. Torri,et al. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients , 2001, Critical care medicine.
[7] L. Reis,et al. TSG‐14 transgenic mice have improved survival to endotoxemia and to CLP‐induced sepsis , 2001, Journal of leukocyte biology.
[8] C. Garlanda,et al. The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. , 2000, Blood.
[9] M. Daha. Mechanisms of mesangial injury in glomerular diseases. , 2000, Journal of nephrology.
[10] G Olivetti,et al. PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. , 2000, Circulation.
[11] A. Mantovani,et al. Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA) , 2000, Clinical and experimental immunology.
[12] T. D. Du Clos. Function of C-reactive protein , 2000, Annals of medicine.
[13] M. Haubitz,et al. Activation of the acute phase response and complement C3 in patients with IgA nephropathy. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] N. Yoshikawa,et al. Role of platelet-activating factor acetylhydrolase gene mutation in Japanese childhood IgA nephropathy. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] R. Foà,et al. Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change. , 1999, The American journal of pathology.
[16] Francesco Tedesco,et al. Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3 , 1997, The Journal of Biological Chemistry.
[17] P. Kimmel. Role of mesangium in microcirculatory control. , 1997, Blood purification.
[18] T. Blundell,et al. Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. , 1996, Blood.
[19] T. Lint,et al. Structure and function of the pentraxins. , 1995, Current opinion in immunology.
[20] J. Robotham,et al. The acute-phase response. , 1995, New horizons.
[21] A. Mantovani,et al. Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. , 1994, Blood.
[22] Ann Chen,et al. Pathogenesis of IgA nephropathy: In vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion , 1994, The Journal of pathology.
[23] G. Camussi. Interactive effects of tumor necrosis factor and platelet-activating factor in the pathogenesis of glomerular injury. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[24] L. McManus,et al. PAF molecular heterogeneity: pathobiological implications. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[25] J. Vilček,et al. TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins. , 1993, Journal of immunology.
[26] M. Rocchi,et al. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. , 1992, The Journal of biological chemistry.
[27] J. Neugarten,et al. Protective effects of specific platelet-activating factor receptor antagonists in experimental glomerulonephritis. , 1991, The Journal of pharmacology and experimental therapeutics.
[28] E. Baldi,et al. Platelet activating factor receptor blockade ameliorates murine systemic lupus erythematosus. , 1990, Kidney international.
[29] G. Camussi,et al. Tumor necrosis factor induces contraction of mesangial cells and alters their cytoskeletons. , 1990, Kidney international.
[30] M. Dunn,et al. Physiology of the mesangial cell. , 1989, Physiological reviews.
[31] G. Camussi,et al. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor , 1987, The Journal of experimental medicine.
[32] G. Camussi,et al. Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin. , 1987, The Journal of laboratory and clinical medicine.
[33] Striker Ge,et al. Glomerular cell culture. , 1985 .
[34] G. Striker,et al. Glomerular cell culture. , 1985, Laboratory investigation; a journal of technical methods and pathology.
[35] L. Baud,et al. Effect of platelet-activating factor and serum-treated zymosan on prostaglandin E2 synthesis, arachidonic acid release, and contraction of cultured rat mesangial cells. , 1984, The Journal of clinical investigation.
[36] H. Gewurz,et al. Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins). , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[37] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.